Research Archive
April 2022
Biopharma / TIGIT Clinical Updates at AACR Incrementally Positive
View research noteMarch 2022
Healthcare Providers and Managed Care / Home Health: More Downside Risk to Ests Against an Improving Operating Backdrop
View research noteFebruary 2022
Biopharma / Key Takeaways from GHC Panel on Bispecifics vs. Cell Therapy in NHL and MM
View research noteJanuary 2022
Healthcare / Liquid Biopsy Nearing the Finish Line in CRC Screening Race
View research noteDecember 2021
Biopharma — Flash / Big Biopharma Will Have $500Bn in Gross Cash to Deploy YE22 – Get Set for M&A
View research noteNovember 2021
Biopharma — Flash / Not to be Alarmist but Omicron is Alarming; Good for PFE & Other Incumbents
View research noteOctober 2021
Healthcare / Over or Underreaction? SVBL Analysts on Molnupiravir and Its Impact
View research noteSeptember 2021
Biopharma / Immuno-Oncology Round-up from ESMO 2021
View research noteAugust 2021
FT516 & FT596 in NHL Give 4 Strong, 3 Weak, and 5 Uncertain Signals
View research noteJuly 2021
VRTX / Seen This Movie Before? Another Biopharma Multiple Compression Saga, PT to $170 / Underperform
View research noteJune 2021
NTRA / Making Sense of the Signatera ADLT; Increasing Estimates, PT to $160 / Outperform
View research noteMay 2021
Life Science Tools and Diagnostics / Comparing Performance of Leading MRD Liquid Biopsy Tests as Early Data Emerges
View research noteApril 2021
Biopharma / Three DC Risks That Could Keep Biopharma Multiples Depressed All Year
View research noteMarch 2021
Life Science Tools and Diagnostics Volatility Creates Opportunities: Highlighting Winners Among the Crash Landing
View research noteFebruary 2021